Reports

Department of Agriculture OIG

COVID-19—Forest Service’s Response to the Coronavirus Pandemic at Recreation Sites

OIG identified the prevention measures that Forest Service established for recreation sites in response to the COVID-19 pandemic.

Full Details: Oversight.gov Report Page

Federal Reserve Board & CFPB OIG

Following Established Processes Helped FRB New York and the Board Reduce Risks Associated With Lending Facility Contracts

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

Early Challenges Highlight Areas for Improvement in COVID-19 Vaccination Programs

Full Details: Oversight.gov Report Page

Inspection / Evaluation | 1/27/2023

Department of Health & Human Services OIG

Challenges With Data From Federal Vaccination Partners Hinder Efforts by State and Local Immunization Programs To Combat COVID-19

Full Details: Oversight.gov Report Page

Inspection / Evaluation | 1/27/2023

Department of Health & Human Services OIG

More Than a Thousand Nursing Homes Reached Infection Rates of 75 Percent or More in the First Year of the COVID-19 Pandemic; Better Protections Are Needed for Future Emergencies

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

Labs With Questionably High Billing for Additional Tests Alongside COVID-19 Tests Warrant Further Scrutiny

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

During the Initial COVID-19 Response, HHS Personnel Who Interacted With Potentially Infected Passengers Had Limited Protections

Full Details: Oversight.gov Report Page

Inspection / Evaluation | 10/31/2022

Department of Health & Human Services OIG

Home Health Agencies Used Multiple Strategies To Respondto the COVID-19 Pandemic, Although Some Challenges Persist

Full Details: Oversight.gov Report Page

Inspection / Evaluation | 10/14/2022

Department of Health & Human Services OIG

FDA’s Work with the Tri-Agency Task Force for Emergency Diagnostics Helped Labs Implement COVID-19 Tests

Full Details: Oversight.gov Report Page

Department of Health & Human Services OIG

FDA Repeatedly Adapted Emergency Use Authorization Policies to Address the Need for COVID-19 Testing

Full Details: Oversight.gov Report Page

Date Range

Report Type

Report Category

Submitting Agency

State/Local Agency

State (State and Local Reports)

Fraud Type

Agency Reviewed

Related Organizations

Management Challenges

Any Recommendations

Any Open Recommendations

Reports

COVID-19—Forest Service’s Response to the Coronavirus Pandemic at Recreation Sites

Following Established Processes Helped FRB New York and the Board Reduce Risks Associated With Lending Facility Contracts

Early Challenges Highlight Areas for Improvement in COVID-19 Vaccination Programs

Challenges With Data From Federal Vaccination Partners Hinder Efforts by State and Local Immunization Programs To Combat COVID-19

More Than a Thousand Nursing Homes Reached Infection Rates of 75 Percent or More in the First Year of the COVID-19 Pandemic; Better Protections Are Needed for Future Emergencies

Labs With Questionably High Billing for Additional Tests Alongside COVID-19 Tests Warrant Further Scrutiny

During the Initial COVID-19 Response, HHS Personnel Who Interacted With Potentially Infected Passengers Had Limited Protections

Home Health Agencies Used Multiple Strategies To Respondto the COVID-19 Pandemic, Although Some Challenges Persist

FDA’s Work with the Tri-Agency Task Force for Emergency Diagnostics Helped Labs Implement COVID-19 Tests

FDA Repeatedly Adapted Emergency Use Authorization Policies to Address the Need for COVID-19 Testing

Glossary

Glossary name will go here